Atalanta Sosnoff Capital, LLC Johnson & Johnson Transaction History

Atalanta Sosnoff Capital, LLC

$4.43 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $42.8 Million - $51.1 Million	-283,673 Reduced 99.38%	1,757 $272,000
Q4 2022 May 22, 2023	BUY	$160.2 - $179.79 $43.4 Million - $48.7 Million	270,775 Added 15411.21%	272,532 $48.1 Million
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $18.5 Million - $20.8 Million	-115,579 Reduced 28.82%	285,430 $50.4 Million
Q3 2022 Oct 12, 2022	SELL	$161.33 - $179.52 $7.55 Million - $8.41 Million	-46,820 Reduced 10.45%	401,009 $65.5 Million
Q2 2022 Jul 14, 2022	SELL	$168.19 - $186.01 $983,070 - $1.09 Million	-5,845 Reduced 1.29%	447,829 $79.5 Million
Q1 2022 Apr 11, 2022	SELL	$158.14 - $179.59 $7.48 Million - $8.49 Million	-47,279 Reduced 9.44%	453,674 $80.4 Million
Q4 2021 Jan 25, 2022	SELL	$155.93 - $173.01 $7.14 Million - $7.92 Million	-45,759 Reduced 8.37%	500,953 $85.7 Million
Q3 2021 Oct 14, 2021	SELL	$161.5 - $179.47 $389,376 - $432,702	-2,411 Reduced 0.44%	546,712 $88.3 Million
Q2 2021 Jul 13, 2021	BUY	$159.48 - $171.07 $6.51 Million - $6.98 Million	40,825 Added 8.03%	549,123 $90.5 Million
Q1 2021 Apr 20, 2021	SELL	$153.07 - $170.48 $421,401 - $469,331	-2,753 Reduced 0.54%	508,298 $83.5 Million
Q4 2020 Jan 14, 2021	SELL	$137.11 - $157.38 $3.99 Million - $4.58 Million	-29,078 Reduced 5.38%	511,051 $80.4 Million
Q3 2020 Oct 14, 2020	BUY	$140.38 - $153.83 $607,143 - $665,314	4,325 Added 0.81%	540,129 $80.4 Million
Q2 2020 Jul 21, 2020	BUY	$128.81 - $155.51 $31.2 Million - $37.7 Million	242,418 Added 82.63%	535,804 $75.4 Million
Q1 2020 Apr 16, 2020	SELL	$111.14 - $153.99 $270,403 - $374,657	-2,433 Reduced 0.82%	293,386 $38.5 Million
Q4 2019 Jan 23, 2020	BUY	$127.5 - $146.44 $9.01 Million - $10.3 Million	70,674 Added 31.39%	295,819 $43.2 Million
Q3 2019 Oct 15, 2019	SELL	$126.95 - $142.14 $1.11 Million - $1.25 Million	-8,770 Reduced 3.75%	225,145 $29.1 Million
Q2 2019 Jul 15, 2019	SELL	$131.15 - $144.24 $623,749 - $686,005	-4,756 Reduced 1.99%	233,915 $32.6 Million
Q1 2019 Apr 09, 2019	BUY	$125.72 - $139.79 $290,036 - $322,495	2,307 Added 0.98%	238,671 $33.4 Million
Q4 2018 Jan 09, 2019	SELL	$122.84 - $147.84 $24.7 Million - $29.8 Million	-201,380 Reduced 46.0%	236,364 $30.5 Million
Q3 2018 Oct 10, 2018	BUY	$121.58 - $142.88 $13.9 Million - $16.4 Million	114,654 Added 35.49%	437,744 $60.5 Million
Q2 2018 Jul 11, 2018	SELL	$119.4 - $131.76 $15.7 Million - $17.3 Million	-131,617 Reduced 28.95%	323,090 $39.2 Million
Q1 2018 Apr 06, 2018	SELL	$125.1 - $148.14 $1.32 Million - $1.56 Million	-10,515 Reduced 2.26%	454,707 $58.3 Million
Q4 2017 Jan 09, 2018	SELL	$131.22 - $143.62 $876,812 - $959,668	-6,682 Reduced 1.42%	465,222 $65 Million
Q3 2017 Oct 10, 2017	BUY	$129.47 - $135.38 $61.1 Million - $63.9 Million	471,904	471,904 $61.4 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.

Account